NSEGeneral Updates▼ NegativeDebt Restruc.7 Aug 2026
Mahanagar Telephone Nigam Limited
General Updates
Mahanagar Telephone Nigam Limited (MTNL) has defaulted on principal and interest payments to several banks, with a total outstanding amount of Rs 9,575 crore. The company has informed the exchanges about the default as per SEBI regulations.
NSEOutcome of Board Meeting▼ NegativeResults6 Aug 2026
Prime Focus Limited
Outcome of Board Meeting
Prime Focus Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a net loss of Rs. 7,946.33 lakhs, compared to a net profit of Rs. 432.33 lakhs in the same period last year. The company has also announced the appointment of a new internal auditor, M/s. Shridhar & Associates, and the designation change of Mr. Namit Malhotra to Whole Time Director and Key Managerial Personnel.
NSEUpdates▼ NegativeRegulatory6 Aug 2026
Sula Vineyards Limited
Updates
Sula Vineyards Limited has informed the Exchange regarding 'Board Comments on the fine levied by NSE and BSE for Non-Compliance of SEBI (LODR) Regulations, 2015.'
NSEOutcome of Board Meeting▼ NegativeResults6 Aug 2026
Digjam Limited
Outcome of Board Meeting
Digjam Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, along with a draft statutory auditor's report. The company's current liabilities exceeded its current assets by Rs. 2,107.75 lakhs as of June 30, 2026. Operations at the company's sole manufacturing facility have been discontinued, and the related assets have been classified as 'Non-current assets held for sale'.
NSEOutcome of Board Meeting▼ NegativeResults6 Aug 2026
Coffee Day Enterprises Limited
Outcome of Board Meeting
Coffee Day Enterprises Limited has submitted its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, showing a revenue of ₹290 Crs, up 8% YoY, EBITDA of ₹52 Crs, down 32% YoY, and a net profit/(loss) of ₹1 Crs, down 96% YoY.
NSEGeneral Updates▼ NegativeRegulatory6 Aug 2026
Medplus Health Services Limited
General Updates
MedPlus Health Services Limited has received three suspension orders for drug licenses of its subsidiary Optival Health Solutions Private Limited due to potential revenue loss of Rs 0.24, Rs 0.17, and Rs 0.23 lakhs.
NSEPress Release▼ NegativeResults6 Aug 2026
HCL Infosystems Limited
Press Release
HCL Infosystems Limited announced its financial results for the quarter ending June 30, 2026, with revenue of Rs. 417.55 Lakhs, lower than the previous quarter. The company reported a loss before tax of Rs.1668.08 Lakhs, higher than the previous quarter's loss. The management attributed the loss to the collection of tax refunds and recovery of receivables from customers through arbitration proceedings.
NSEInitiation of Forensic Audit▼ NegativeRegulatory6 Aug 2026
Nath Bio-Genes (India) Limited
Initiation of Forensic Audit
Nath Bio-Genes (India) Limited has received a communication from SEBI to appoint a forensic auditor to conduct an audit of the company's books of account and records for the financial years 2020-21 to 2025-26.
NSEInitiation of Forensic Audit▼ NegativeRegulatory6 Aug 2026
Techindia Nirman Limited
Initiation of Forensic Audit
Techindia Nirman Limited has informed the Exchange about Initiation of Forensic Audit by SEBI. The Company has received a communication from SEBI, informing the Company that SEBI has appointed CNK & Associates LLP as the Forensic Auditor to conduct a forensic audit in respect of the Company. The forensic audit shall examine the books of account and records of the Company for the financial years 2020-21 to 2025-26.
NSEInitiation of Forensic Audit▼ NegativeRegulatory6 Aug 2026
Agri-Tech (India) Limited
Initiation of Forensic Audit
Agri-Tech (India) Limited has informed the Exchange about Initiation of Forensic Audit by SEBI, which will examine the company's books of account and records for the financial years 2020-21 to 2025-26.
NSEOutcome of Board Meeting▼ NegativeResults6 Aug 2026
Sambhaav Media Limited
Outcome of Board Meeting
Sambhaav Media Limited has submitted its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with a net loss of ₹100.74 crores.
NSEOutcome of Board Meeting▼ NegativeResults6 Aug 2026
Suven Life Sciences Limited
Outcome of Board Meeting
Suven Life Sciences Limited has announced its un-audited financial results for the quarter ended June 30, 2026, with a net loss of Rs. 12,76,03 lakhs and a total comprehensive loss of Rs. 12,76,03 lakhs.
NSEPendency of Litigation(s)/dispute(s) or the outcome impacting the Company▼ NegativeInsolvency5 Aug 2026
Reliance Infrastructure Limited
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Reliance Infrastructure Limited has informed the Exchange about the admission of a petition under Section 7 of the Insolvency and Bankruptcy Code, 2016 by State Bank of India against its wholly-owned subsidiary KM Toll Road Private Limited for a claim amount of INR 233.44 crore, including interest. The company's exposure to KM Toll Road is already provided for in its books of accounts.
NSEPendency of Litigation(s)/dispute(s) or the outcome impacting the Company▼ NegativeLitigation5 Aug 2026
JSW Dulux Limited
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
JSW Dulux Limited has informed the Exchange about the pendency of a litigation/dispute with the Karnataka GST Department, which may impact the company. The dispute is related to the disallowance of Input Tax Credit for the period from April 2020 to March 2021, aggregating to Rs. 118,33,32,869/-.
NSEGeneral Updates▼ NegativeRegulatory5 Aug 2026
Medplus Health Services Limited
General Updates
MedPlus Health Services Limited has received a suspension order for a Drug License of a store situated in Karnataka due to a contravention under the Drugs and Cosmetics Act, resulting in a potential revenue loss of Rs 0.71 lacs.
NSECessation▼ NegativeMgmt Change5 Aug 2026
Stanley Lifestyles Limited
Cessation
Stanley Lifestyles Limited has informed the Exchange regarding Cessation of Mr. Mukesh Sharma as Company Secretary & Compliance Officer of the company with immediate effect, due to certain acts and conduct on his part considered inconsistent with the duties, responsibilities and professional standards expected from the office.
NSEOutcome of Board Meeting▼ NegativeResults5 Aug 2026
Shree Renuka Sugars Limited
Outcome of Board Meeting
Shree Renuka Sugars Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, showing revenue from operations at ₹19,686 crore and a loss before tax of ₹12,810 crore.
NSECorporate Insolvency Resolution Process▼ NegativeInsolvency5 Aug 2026
Shrenik Limited
Corporate Insolvency Resolution Process
Shrenik Limited has been admitted to corporate insolvency resolution process (CIRP) by the National Company Law Tribunal, Ahmedabad Bench, due to a default of Rs. 5,92,78,324. An interim resolution professional has been appointed, and a moratorium has been imposed, prohibiting all actions against the company. Creditors are called upon to submit their claims by 18-08-2026.
NSECorporate Insolvency Resolution Process▼ NegativeInsolvency5 Aug 2026
DPSC Limited
Corporate Insolvency Resolution Process
DPSC Limited has informed the Exchange about Corporate Insolvency Resolution Process regarding Intimation of the Meeting of the Suspended Board of Directors with the Interim Resolution Professional (IRP) (Management Committee) pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
NSEOutcome of Board Meeting▼ NegativeResults5 Aug 2026
BALAXI PHARMACEUTICALS LIMITED
Outcome of Board Meeting
Balaxi Pharmaceuticals Limited has announced its standalone and consolidated unaudited financial results for the quarter ended 30th June, 2026. The company has reported a net loss of Rs. 125.32 lakhs, with a basic EPS of Rs. (0.23) and a diluted EPS of Rs. (0.23). The company has also commenced commercial production at its first pharmaceutical formulation manufacturing facility at Jadcherla, Hyderabad, and has received manufacturing product permissions for an additional 29 products.